Table 1 Clinicopathological features of the cohort of 470 grade III invasive ductal carcinomas of no special type
Parameter | Number |
|---|---|
Age in years | Â |
   Range | 21–85 (mean 53.2) |
   <35 | 36 (8%) |
   35–50 | 142 (32%) |
   51–65 | 189 (43%) |
   >65 | 76 (17%) |
Menopausal status | Â |
   Premenopausal | 175 (40%) |
   Perimenopausal | 64 (15%) |
   Postmenopausal | 195 (45%) |
   Unknown | 9 |
Tumour size | Â |
   Range | 0.5–10.5 cm (mean 3.4 cm) |
   p1 | 27 (6%) |
   p2 | 313 (72%) |
   p3 | 93 (21%) |
Axillary nodes | Â |
   Positive | 251 (57%) |
   Negative | 184 (42%) |
Oestrogen receptor | Â |
   Positive | 191 (46%) |
   Negative | 222 (54%) |
   Not available | 30 |
Surgical management | Â |
   None | 2 (1%) |
   Mastectomy | 318 (72%) |
   Tumourectomy | 123 (28%) |
Adjuvant treatment | Â |
   None | 229 (52%) |
   Tamoxifen/Ovarian oblation | 103 (22%) |
   Chemotherapy and tamoxifen | 5 (1%) |
   Chemotherapy | 112 (25%) |
Length of follow-up in months | 3.2–333.5 (mean 116.4) |